FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Shionogi's Free Cash Flow for the
three
months ended in Mar. 2026 was €0 Mil. Shionogi's Revenue for the
three
months ended in Mar. 2026 was €758 Mil. Therefore, Shionogi's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.
The historical rank and industry rank for Shionogi's FCF Margin % or its related term are showing as below:
FRA:SH0'
s FCF Margin % Range Over the Past 10 Years
Min: 21.04 Med: 32.72 Max: 37.94
Current: 31.09
During the past 13 years, the highest FCF Margin % of Shionogi was 37.94%. The lowest was 21.04%. And the median was 32.72%.
FRA:SH0's FCF Margin % is ranked better than 95.41% of 958
companies
in the Drug Manufacturers industry
Industry Median: 2.51
vs FRA:SH0: 31.09
Shionogi FCF Margin % Related Terms
Shionogi FCF Margin % Historical Data
* Premium members only.
The historical data trend for Shionogi's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Shionogi's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shionogi FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shionogi's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Shionogi's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shionogi (FRA:SH0) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Shionogi and its competitors. Over the past decade, Shionogi's FCF Margin % has ranged from 21.04 to 37.94. According to the industry distribution chart, Shionogi ranks #44 out of 958 companies in the Drug Manufacturers industry, placing it in the top 4.6%.
Is Shionogi's FCF Margin % too high?
Shionogi's current FCF Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 21.04 to a high of 37.94. Based on the distribution chart, Shionogi ranks #44 out of 958 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Shionogi has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shionogi's FCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Shionogi ranks #44 out of 958 companies for FCF Margin %. This places Shionogi in the top 5% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 2.51. Historically, Shionogi's own FCF Margin % has ranged from 21.04 to 37.94 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.51, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Shionogi and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shionogi's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shionogi stock overvalued right now?
Based on GuruFocus' analysis, Shionogi (FRA:SH0) is currently considered Fairly Valued. The stock's GF Value™ is €15.06, compared to a current price of €14.45 — trading 4.1% below its estimated fair value. The current FCF Margin % is 0.00%. Shionogi's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Shionogi (FRA:SH0), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shionogi (FRA:SH0) Overvalued in 2026?
Based on GuruFocus' analysis, Shionogi stock appears to be undervalued.
The current stock price of €14.45 is trading 4.1% below its estimated GF Value™ of €15.06.
GuruFocus considers Shionogi to be Fairly Valued.
Key valuation signals for FRA:SH0:
FCF Margin %: 0.00%
GF Value™: €15.06 vs. price of €14.45 (4.1% below fair value)
No single metric tells the full story. See the FRA:SH0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shionogi & Co Ltd is a specialty and generic drug manufacturing company. The company focuses on the manufacturing and distribution of pharmaceuticals, diagnostic reagents, and medical devices. The company engages in manufacturing, formulation, packaging, and analysis as part of its commercialization research that spans late-stage drug discovery through commercial production. It provides products and services in Japan, Europe, North America, and other regions.
93GF Score
Get the complete analysis for FRA:SH0
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:SH0 has been successfully added to your 
